PEX39
gene geneOn this page
Also known as LOC441150
Summary
PEX39 (peroxisomal biogenesis factor 39, HGNC:34431) is a protein-coding gene on chromosome 6p21.1, encoding Peroxisomal biogenesis factor 39 (Q5I0X4). May be a peroxin involved in the PTS2-mediated protein import pathway.
Predicted to be located in peroxisome.
Source: NCBI Gene 441150 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- MANE Select transcript:
NM_001008739
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34431 |
| Approved symbol | PEX39 |
| Name | peroxisomal biogenesis factor 39 |
| Location | 6p21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LOC441150 |
| Ensembl gene | ENSG00000221821 |
| Ensembl biotype | protein_coding |
| Entrez | 441150 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000408925
RefSeq mRNA: 1 — MANE Select: NM_001008739
NM_001008739
CCDS: CCDS43463
Canonical transcript exons
ENST00000408925 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001574993 | 42890265 | 42890821 |
Expression profiles
Bgee: expression breadth ubiquitous, 209 present calls, max score 90.21.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.5111 / max 105.4792, expressed in 1748 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 73640 | 15.5111 | 1748 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right adrenal gland | UBERON:0001233 | 90.21 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 90.18 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 89.90 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 89.80 | gold quality |
| left adrenal gland | UBERON:0001234 | 89.71 | gold quality |
| adenohypophysis | UBERON:0002196 | 88.62 | gold quality |
| adrenal cortex | UBERON:0001235 | 88.49 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.04 | gold quality |
| mucosa of stomach | UBERON:0001199 | 88.04 | gold quality |
| pituitary gland | UBERON:0000007 | 86.79 | gold quality |
| skin of leg | UBERON:0001511 | 86.65 | gold quality |
| hypothalamus | UBERON:0001898 | 86.33 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 86.24 | gold quality |
| right lung | UBERON:0002167 | 86.18 | gold quality |
| adrenal gland | UBERON:0002369 | 86.10 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 85.89 | gold quality |
| lower esophagus | UBERON:0013473 | 85.84 | gold quality |
| apex of heart | UBERON:0002098 | 85.75 | gold quality |
| monocyte | CL:0000576 | 85.57 | gold quality |
| tibial artery | UBERON:0007610 | 85.55 | gold quality |
| popliteal artery | UBERON:0002250 | 85.53 | gold quality |
| leukocyte | CL:0000738 | 85.40 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 85.40 | gold quality |
| skin of abdomen | UBERON:0001416 | 85.39 | gold quality |
| putamen | UBERON:0001874 | 85.09 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.03 | silver quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 85.00 | gold quality |
| nucleus accumbens | UBERON:0001882 | 84.81 | gold quality |
| granulocyte | CL:0000094 | 84.76 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 84.60 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
7 targeting PEX39, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-876-3P | 98.76 | 68.23 | 945 |
| HSA-MIR-4722-5P | 98.46 | 66.34 | 1611 |
| HSA-MIR-3169 | 96.40 | 67.58 | 698 |
| HSA-MIR-4740-5P | 96.25 | 67.96 | 726 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Pex39 | ENSMUSG00000062619 |
| rattus_norvegicus | C9h6orf226 | ENSRNOG00000079593 |
Protein
Protein identifiers
Peroxisomal biogenesis factor 39 — Q5I0X4 (reviewed: Q5I0X4)
All UniProt accessions (1): Q5I0X4
UniProt curated annotations — full annotation on UniProt →
Function. May be a peroxin involved in the PTS2-mediated protein import pathway.
Subcellular location. Peroxisome.
RefSeq proteins (1): NP_001008739* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR039995 | PEX39 | Family |
| IPR040554 | KPWE_PEX14_dom | Domain |
Pfam: PF17733
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5I0X4-F1 | 71.85 | 0.18 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 49 (showing top):
ACEVEDO_LIVER_CANCER_UP, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, GOCC_MICROBODY, LU_EZH2_TARGETS_UP, WIERENGA_STAT5A_TARGETS_DN, VANOEVELEN_MYOGENESIS_SIN3A_TARGETS, BOUDOUKHA_BOUND_BY_IGF2BP2, EIF4E_UP, ATF6_TARGET_GENES, CHAF1B_TARGET_GENES, EMX1_TARGET_GENES, HES4_TARGET_GENES, NFE2L1_TARGET_GENES, OVOL3_TARGET_GENES, SKIL_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): peroxisome (GO:0005777)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| microbody | 1 |
Protein interactions and networks
STRING
156 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PEX39 | A0A0J9YXS1 | A0A0J9YXS1 | 662 |
| PEX39 | C1orf122 | Q6ZSJ8 | 507 |
| PEX39 | TIGD5 | Q53EQ6 | 507 |
| PEX39 | B8ZZ87 | B8ZZ87 | 480 |
| PEX39 | EFCAB5 | A4FU69 | 447 |
| PEX39 | SLX9 | Q9NSI2 | 444 |
| PEX39 | ZNF358 | Q9NW07 | 435 |
| PEX39 | SLC33A2 | Q96ES6 | 419 |
| PEX39 | NECAP2 | Q9NVZ3 | 419 |
| PEX39 | SCAND1 | P57086 | 394 |
| PEX39 | RRP1B | Q14684 | 378 |
| PEX39 | DNPH1 | O43598 | 373 |
| PEX39 | ALDH16A1 | Q8IZ83 | 373 |
| PEX39 | ALKBH7 | Q9BT30 | 370 |
| PEX39 | LY6G6C | O95867 | 370 |
IntAct
29 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| APPBP2 | PEX39 | psi-mi:“MI:0915”(physical association) | 0.720 |
| PEX39 | APPBP2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| PEX39 | CCNDBP1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| PEX39 | HNRNPK | psi-mi:“MI:0915”(physical association) | 0.670 |
| CCNDBP1 | PEX39 | psi-mi:“MI:0915”(physical association) | 0.670 |
| HNRNPK | PEX39 | psi-mi:“MI:0915”(physical association) | 0.670 |
| KRT40 | PEX39 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PEX39 | TEX11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PEX39 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEX11 | PEX39 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PEX39 | PEX7 | psi-mi:“MI:0914”(association) | 0.530 |
| ACAA1 | PEX7 | psi-mi:“MI:0914”(association) | 0.530 |
| PHYH | PEX7 | psi-mi:“MI:0914”(association) | 0.350 |
| PEX7 | PFDN6 | psi-mi:“MI:0914”(association) | 0.350 |
| PEX39 | APPBP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (18): C6orf226 (Two-hybrid), C6orf226 (Two-hybrid), C6orf226 (Two-hybrid), C6orf226 (Two-hybrid), C6orf226 (Two-hybrid), C6orf226 (Affinity Capture-MS), C6orf226 (Affinity Capture-MS), ACAA1 (Affinity Capture-MS), PEX7 (Affinity Capture-MS), PHYH (Affinity Capture-MS), C6orf226 (Two-hybrid), C6orf226 (Two-hybrid), ACAA1 (Affinity Capture-MS), PEX7 (Affinity Capture-MS), PHYH (Affinity Capture-MS)
ESM2 similar proteins: A0A1D5AG16, A4Y0M0, A8IYS6, A8QA64, C6FX52, G2WWH6, J9VQE5, O13904, O18811, O68586, O83706, P0C8B4, P0C8B5, P0C8P9, P31962, P31963, P34069, P34166, P56650, P78742, P78743, P97516, P9WES8, P9WL02, P9WL03, Q02594, Q12373, Q2PE14, Q4PDA7, Q4RTJ5, Q4W9G3, Q4WIN1, Q5I0X4, Q62857, Q67593, Q69T21, Q6CHP5, Q753S8, Q75DE8, Q75E62
Diamond homologs: Q5I0X4, Q9D727
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
136 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:42890691:T:TA | donor_gain | 0.9200 |
| 6:42890620:T:TA | donor_gain | 0.8900 |
| 6:42890559:AT:A | donor_gain | 0.7900 |
| 6:42890588:A:AC | donor_gain | 0.7900 |
| 6:42890604:T:TA | donor_gain | 0.7900 |
| 6:42890806:G:T | donor_gain | 0.7800 |
| 6:42890784:T:A | donor_gain | 0.7700 |
| 6:42890560:T:TA | donor_gain | 0.7600 |
| 6:42890636:CG:C | donor_gain | 0.7400 |
| 6:42890588:AGC:A | donor_gain | 0.7300 |
| 6:42890649:C:CA | donor_gain | 0.7200 |
| 6:42890785:C:CA | donor_gain | 0.7200 |
| 6:42890739:G:C | donor_gain | 0.7000 |
| 6:42890648:G:A | donor_gain | 0.6700 |
| 6:42890697:C:CA | donor_gain | 0.6700 |
| 6:42890601:G:GA | donor_gain | 0.6500 |
| 6:42890529:A:C | donor_gain | 0.6400 |
| 6:42890318:A:C | donor_gain | 0.6200 |
| 6:42890803:C:A | donor_gain | 0.6200 |
| 6:42890449:C:CA | donor_gain | 0.6100 |
| 6:42890802:T:TA | donor_gain | 0.6000 |
| 6:42890526:TCA:T | donor_gain | 0.5900 |
| 6:42890555:T:A | donor_gain | 0.5900 |
| 6:42890485:AGGGG:A | donor_gain | 0.5600 |
| 6:42890418:A:C | donor_gain | 0.5500 |
| 6:42890621:C:CA | donor_gain | 0.5500 |
| 6:42890493:A:AC | donor_gain | 0.5300 |
| 6:42890696:G:A | donor_gain | 0.5300 |
| 6:42890523:G:GA | donor_gain | 0.5200 |
| 6:42890614:TGG:T | donor_gain | 0.5100 |
AlphaMissense
618 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:42890606:C:A | W61C | 0.991 |
| 6:42890606:C:G | W61C | 0.991 |
| 6:42890612:C:A | K59N | 0.987 |
| 6:42890612:C:G | K59N | 0.987 |
| 6:42890608:A:G | W61R | 0.985 |
| 6:42890608:A:T | W61R | 0.985 |
| 6:42890718:A:G | L24P | 0.971 |
| 6:42890614:T:C | K59E | 0.967 |
| 6:42890706:A:T | V28D | 0.963 |
| 6:42890613:T:G | K59T | 0.960 |
| 6:42890607:C:A | W61L | 0.956 |
| 6:42890604:T:A | E62V | 0.949 |
| 6:42890603:C:A | E62D | 0.942 |
| 6:42890603:C:G | E62D | 0.942 |
| 6:42890604:T:C | E62G | 0.937 |
| 6:42890607:C:G | W61S | 0.933 |
| 6:42890697:C:A | G31V | 0.916 |
| 6:42890613:T:A | K59M | 0.912 |
| 6:42890614:T:G | K59Q | 0.909 |
| 6:42890715:A:G | L25P | 0.903 |
| 6:42890709:A:G | L27P | 0.900 |
| 6:42890605:C:T | E62K | 0.894 |
| 6:42890604:T:G | E62A | 0.890 |
| 6:42890608:A:C | W61G | 0.889 |
| 6:42890718:A:T | L24H | 0.884 |
| 6:42890730:G:A | T20I | 0.872 |
| 6:42890643:G:T | P49H | 0.867 |
| 6:42890664:A:T | I42N | 0.861 |
| 6:42890698:C:G | G31R | 0.852 |
| 6:42890698:C:A | G31C | 0.849 |
dbSNP variants (sampled 300 via entrez): RS1000382508 (6:42892536 G>A,C), RS1002628128 (6:42890939 T>A,C), RS1003223887 (6:42889812 C>T), RS1004055453 (6:42890707 C>A,G,T), RS1004986807 (6:42891007 G>A,T), RS1005991509 (6:42892272 A>G), RS1009550364 (6:42890319 C>T), RS1010611498 (6:42891442 G>T), RS1011089297 (6:42889915 G>A), RS1012532578 (6:42891855 C>T), RS1013554868 (6:42891335 T>C), RS1013787128 (6:42891109 C>G,T), RS1014824197 (6:42892305 T>C), RS1015230206 (6:42890780 A>T), RS1016520994 (6:42891664 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002395_473 | Mean platelet volume | 2.000000e-23 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| trichostatin A | affects cotreatment, decreases expression | 3 |
| Benzo(a)pyrene | decreases methylation, increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| jinfukang | increases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Quercetin | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.